Stock profile

Sartorius AG(SRT3.DE)

Country: GermanySector: HealthcareIndustry: Medical - Instruments & SuppliesExchange: XETRA
P/E TTM
101.4
History
P/E NTM
41.1
Market cap
15.28B
Currency EUR
KvantraRanki26
Value22
Quality10
Momentum55
Current price
238.30-0.13%
Benchmarks

No price history available.

Key financial summary

Financials in EUR
202020212022202320242025TTM2026E
Total revenue€m2,3363,4494,1753,3963,3813,538N/AN/A
Operating profit€mLockedLockedLockedLockedLockedLockedLockedLocked
Net profit€m32142791320584155N/AN/A
EPS reportedLockedLockedLockedLockedLockedLockedLockedLocked
Operating cashflow per shareLockedLockedLockedLockedLockedLockedLockedLocked
Capex per shareLockedLockedLockedLockedLockedLockedLockedLocked
FCF per shareLockedLockedLockedLockedLockedLockedLockedLocked
Free cash flow€mLockedLockedLockedLockedLockedLockedLockedLocked
Net debt€mLockedLockedLockedLockedLockedLockedLockedLocked
Book value equity€mLockedLockedLockedLockedLockedLockedLockedLocked
Book value per shareLockedLockedLockedLockedLockedLockedLockedLocked
Number of sharesmLockedLockedLockedLockedLockedLockedLockedLocked
DPS (TTM paid)LockedLockedLockedLockedLockedLockedLockedLocked

Financial summary

Financials in EUR
202020212022202320242025TTM2026E
Value
P/E LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/B LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/S LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/FCF LTMxLockedLockedLockedLockedLockedLockedLockedLocked
EV/EBITDA LTMxLockedLockedLockedLockedLockedLockedLockedLocked
EV/Sales LTMxLockedLockedLockedLockedLockedLockedLockedLocked
Earnings Yield LTM%LockedLockedLockedLockedLockedLockedLockedLocked
FCF Yield%LockedLockedLockedLockedLockedLockedLockedLocked
Quality
ROE%LockedLockedLockedLockedLockedLockedLockedLocked
ROIC%LockedLockedLockedLockedLockedLockedLockedLocked
Operating margin%LockedLockedLockedLockedLockedLockedLockedLocked
Gross margin%LockedLockedLockedLockedLockedLockedLockedLocked
FCF/Sales%LockedLockedLockedLockedLockedLockedLockedLocked
Growth and momentum
EPS Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
Sales Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
Net Income Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
FCF Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Operating Profit Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Dividend and capital structure
Dividend Yield%LockedLockedLockedLockedLockedLockedLockedLocked
Dividend Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Payout Ratio%LockedLockedLockedLockedLockedLockedLockedLocked
FCF/DebtxLockedLockedLockedLockedLockedLockedLockedLocked
Net Debt/EBITDAxLockedLockedLockedLockedLockedLockedLockedLocked
EBIT/Net interestxLockedLockedLockedLockedLockedLockedLockedLocked
Net debt/market cap%LockedLockedLockedLockedLockedLockedLockedLocked
Net debt/Equity%LockedLockedLockedLockedLockedLockedLockedLocked
Gross debt/equity%LockedLockedLockedLockedLockedLockedLockedLocked

Ratings

Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked
Number of covering analystsLocked

Based on consensus from external analysts. Not Kvantra's opinion.

Company overview

Sartorius AG is a global supplier of advanced bioprocess and laboratory solutions, offering a comprehensive portfolio of products and services essential for life science research and biopharmaceutical manufacturing. The company's offerings include sophisticated biosensors and detection systems, live-cell analysis platforms, and a wide array of cell culture media and reagents. Sartorius also manufactures various bioreactors, ranging from benchtop to large-scale single-use and stainless steel systems, along with their associated software applications. Its extensive filtration product line encompasses membranes, specialized filters, and diverse devices for ultrafiltration, sterile filtration, and sample preparation. Furthermore, Sartorius provides process chromatography and fluid management solutions, industrial microbiology systems, water purification units, and essential lab equipment such as weighing, pipetting, and centrifugation systems. Beyond products, the company delivers critical services including bioprocess development, protein expression, and validation. Serving sectors like life science research, biopharmaceutical manufacturing, and quality control, Sartorius was established in 1870 and is headquartered in Göttingen, Germany.

SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryGermany
Trades inEUR

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Sartorius AG (SRT3.DE)

SRT3.DE · XETRA · Healthcare
238.30-0.13%
Sign up to track this stock

No price history available.

KvantraRank26
P/E TTM101.4
P/E NTM41.1
Market cap15.28B
KvantraRank26 / 100
Value
22
Quality
10
Momentum
55
Financialsin EUR
20242025TTM2026E
Ratings
Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked

Based on consensus from external analysts. Not Kvantra's opinion.

About

Sartorius AG is a global supplier of advanced bioprocess and laboratory solutions, offering a comprehensive portfolio of products and services essential for life science research and biopharmaceutical manufacturing. The company's offerings include sophisticated biosensors and detection systems, live-cell analysis platforms, and a wide array of cell culture media and reagents. Sartorius also manufactures various bioreactors, ranging from benchtop to large-scale single-use and stainless steel systems, along with their associated software applications. Its extensive filtration product line encompasses membranes, specialized filters, and diverse devices for ultrafiltration, sterile filtration, and sample preparation. Furthermore, Sartorius provides process chromatography and fluid management solutions, industrial microbiology systems, water purification units, and essential lab equipment such as weighing, pipetting, and centrifugation systems. Beyond products, the company delivers critical services including bioprocess development, protein expression, and validation. Serving sectors like life science research, biopharmaceutical manufacturing, and quality control, Sartorius was established in 1870 and is headquartered in Göttingen, Germany.

SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryGermany
Trades inEUR

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data for this stock

Unlimited access to every company

See plans

Unlock all fundamental data for this stock

Unlimited access to every company

See plans